Multiple Endocrine Neoplasia - 46 Studies Found
Recruiting |
: Studies of Inherited Diseases of Metabolism :
|
Active, not recruiting |
: Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer :
|
Not yet recruiting |
: Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment : Pancreatic Neuroendocrine Tumors in MEN1 : 2016-03-02 : Drug: Somatostatin-Analog A long-acting somatostatin-analog will be applied. |
Not yet recruiting |
: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor :
|
Completed |
: High Dose Somatostatin Analogues in Neuroendocrine Tumors :
|
Recruiting |
: Familial Investigations of Childhood Cancer Predisposition :
|
Terminated |
: A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors :
|
Completed |
: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer :
|
Recruiting |
: Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors) :
: 2017-02-02 :
|
Recruiting |
: Genetic Evaluation of Families With Endocrine Cancers :
: 2013-02-15 : Genetic: Blood draw Blood draw |